This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Hemostasis Products Market

Increasing number of trauma and surgical cases and technological advancements boding well for market growth

Hemostasis Product Market by Product, Application, End-Use & Region- Forecast 2022 – 2032

Hemostasis Products Market Outlook (2022-2032)

[307 Pages Report] In 2022, the global hemostasis products market is likely to hold a value of US$ 1580 Million. With a CAGR of 5.3%, the market is projected at US$ 2638 Million during the forecast period from 2022 to 2032. Expansion of the market can be attributed to the increasing prevalence of chronic blood disorders.

Data points

Key Statistics

Global Hemostasis Products Market CAGR (2022-to 2032)

5.3%

Global Hemostasis Products Market Size (2022)

US$ 1,580 Million

Global Hemostasis Products Market Size (2032)

US$ 2,638 Million

Hemostasis can be achieved in various other ways if the body cannot do it naturally (or needs help) during surgery or medical treatment. When the body is under shock and stress, hemostasis is harder to achieve. Hemostasis can be achieved by chemical agents as well as mechanical or physical agents. Which hemostasis type is used is determined based on the situation.

Topical hemostatic agents (physical agents, biologically active agents) and tissue adhesives are used as an adjunct or alternative to standard surgical techniques to manage bleeding from surgical surfaces, and are particularly useful for diffuse non-anatomic bleeding, bleeding associated with sensitive structures, and bleeding in patients with hemostatic abnormalities.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Factors Driving the Global Hemostasis Products Market?

An increase in the number of accidents and trauma cases will propel the growth of the hemostasis products market

An increase in accident and trauma cases across the globe will drive the hemostasis products market growth. An increasing number of surgeries performed across the globe is anticipated to boost the demand for hemostasis products, as these products play a vital role in wound healing. The leading causes of surgeries are cardiovascular disease and stroke, cancer and injury. And any surgical procedure can develop severe complications and result into uncontrollable bleeding thus increasing demand for hemostasis product.

For instance, globally, 310 million major surgeries are performed each year; around 40 to 50 million in USA and 20 million in Europe. It is estimated that 1–4% of these patients will die, up to 15% will have serious postoperative morbidity, and 5–15% will be readmitted within 30 days. Thus the increasing number of accident and trauma cases coupled with the increase in surgical procedures will create lucrative opportunities for the hemostasis products market during the forecasting period.

Technological advancement in the healthcare sector to boost the growth of the market

High-level technological advancements, strong economies, and a swarming pool of patients with a variety of blood disorders are the chief factors that will boost the market for hemostasis products in the near future. The technological advancement in healthcare and high investment is research and development are also driving the hemostasis products market in the forecasting period.

The rapidly growing medical tourism sector coupled with high investment made by governments of various countries towards the growth of the healthcare sector will provide lucrative opportunities for the growth of the market. The growing investments in the healthcare sector by various government and non-government companies bode well for the growth of the hemostasis products market. For instance, EndoClot Plus, Inc. announced that U.S. Food and Drug Administration (FDA) has approved EndoClot Polysaccharide Hemostatic System, an innovative product that assists Gastroenterologists to stop bleeding rapidly.

Which Factors Are Restraining the Growth of the Hemostasis Products Market?

High cost associated with hemostasis products may restrain the growth of the market

Although the hemostasis products market has numerous end-uses, there are some obstacles that likely pose a challenge to market growth during the forecasting period. The developing region with limited healthcare spending and lack of skilled professionals for carrying out the surgical procedure may impede the growth of the market in coming years.

The high expenses related to hemostat products may also impede the growth of the market in the forecasting period. Also, stringent regulatory policies and the use of off-label products are projected to restrain the market's growth over the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Hemostasis Products Markets

Global Hemostasis Products market:

Attributes

Global Hemostasis Products market

CAGR (2022- to 2032)

5.3%

Market Value (2032)

US$ 2638Million

Growth Factor

An increase in the number of trauma and surgical procedures and the increasing prevalence of chronic blood disorders is expected to boost the market in the forecast period.

Opportunities

High investment in healthcare sector development by government authorities

are anticipated to offer opportunities for expansion in the forecast period.

Global Hemostatic Gel Market:

Attributes

Global Hemostatic Gel Market

CAGR (2022- to 2032)

6.8%

Market Value (2032)

US$ 1.9Billion

Growth Factor

The growing interest in developing new hemostatic agents is due to unmet needs in modifying uncontrolled hemorrhages in emergency care, surgical procedures, and frontline situations is expected to boost market growth in the forecast period.

Opportunities

The global rise in the incidence of chronic diseases, and the volume of surgical procedures is expected to offer significant opportunities for market expansion in the forecast period.

Global Hemostasis Diagnostic Market Market:

Attributes

Global Hemostasis Diagnostic Market Market

CAGR (2022- to 2032)

6.7%

Market Value (2032)

US$ 4.05Billion

Growth Factor

Rising healthcare infrastructure, high adoption of advanced automated analyzers, and presence of a large patient pool is anticipated to expand the market growth in the forecast period.

Opportunities

Increase in number of hospitals, increase in incidence of cardiovascular diseases, and growing adoption of hemostasis diagnostics as part of the treatment of diseases , is expected to offer significant opportunities for expansion in the coming time

Country-wise Analysis

Will North America Continue Dominance in the Global Hemostasis Products Market?

Rise in prevalence of cardiovascular diseases and blood clotting disorders to propel the growth of the market

The North America hemostasis products market is expected to accumulate a market share of 29.5% in 2021 and the trend is forecast to continue over the assessment period. On a geographic basis, North America is anticipated to be the largest market for hemostasis products market due to rising healthcare infrastructure, high adoption of advanced automated analyzers, and the presence of a large patient pool. For instance, in 2018, Sysmex Corporation launched its next-generation analyzers in the hemostasis field - the Automated Blood Coagulation Analyzers CN-6000 and CN-3000.

Furthermore, the technological advancements have increased access to healthcare services, and the entry of new manufacturers is likely to fuel market expansion in the region over the years to come. In addition, the increasing prevalence of numerous blood clot disorders is aggressively propelling demand for hemostasis diagnosis. According to the US Centers for Disease Control and Prevention (CDC), hemophilia occurs in approximately 1 in 5,617 live male births. There are between 30,000 – 33,000 males with hemophilia in the US.

How Will Growth of the European Hemostasis Products Market Unfold?

The presence of an advanced healthcare system in the region provides growth avenues

Europe is expected to accumulate a significant market in the hemostasis products market in the forecasting period. Europe also offers potential growth opportunities in the hemostasis products market due to the increased prevalence of various hemostasis disorders, the presence of regional and international market players, and massive investments in R&D across the country are expected to boost the growth of the market in the region.

Increasing awareness about the use of hemostatic agents, adhesives, and tissue sealants to avoid the risk of postoperative bleeding propels the demand for hemostasis products. Furthermore, improving healthcare infrastructure, increasing the focus of emerging and leading market players on developing markets, rise in the number of hospitals, increasing the incidence of cardiovascular diseases, and growing adoption of hemostasis diagnostics products as part of the treatment of diseases are some of the key factors that have driven demand for hemostasis diagnostics in Europe.

Will the Asia Pacific emerge as an Attractive Hemostasis Products Market?

Presence of top pharma and biotech companies to drive the growth of the market

Asia Pacific region is expected to show a higher market attractiveness index and is considered to be the most lucrative market. This region is expected to dominate the global hemostasis products market in terms of revenue share and grow at a comparatively higher growth rate than other regions due to the presence of a technologically advanced healthcare system with advanced treatments and a large number of patients in countries like India, China, and Japan.

The growth of the hemostasis products market in the Asia Pacific is attributed to the presence of top pharma and biotech companies that are involved in the development of therapeutics and a well-established healthcare infrastructure boosts the growth of the hemostasis products market. Also, increasing demand for hemostasis products and the rising prevalence of the cardiovascular disorder in the region provides opportunities for growth of the market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Analysis

By Application, which Category of the Hemostasis Product Market will remain prominent?

The myocardial infarction segment accounts for the highest market share of the hemostasis products market

Based on application, the hemostasis products market is segmented into trauma, surgeries, hemophilia, and myocardial infarction. Among these, the myocardial infarction segment is likely to account for the largest share of the global hemostasis products market during the forecast period.

The myocardial infarction segment dominated the market with a revenue share of over 19.5% in 2021 and is expected to register the highest CAGR from 2022 to 2032.The main factor driving the growth of the segment is increasing cardiovascular disease prevalence globally owing to sedentary lifestyle, unhealthy eating habits, excessive intake of alcohol, and smoking.

On the other hand, the hemophilia segment accounts for a significant share of the hemostasis products market. As the growing number of surgeries boosts and the use of hemostasis products for the treatment of hemophilia was the leading contributor to the global market during the forecasting period.

Based On Product, Which Segment Accounts for Maximum Hemostasis Products Market Growth?

Topical Hemostat Segment to Remain the Most Lucrative for hemostasis products market

FMI’s latest report on the hemostasis products market forecast the topical hemostasis segment account for the largest market share of more than 68.5% in 2021 and is anticipated to witness significant growth during the forecast period. The topical hemostasis products are in demand as they are cost-effective, efficient, easy to use, and also biodegradable in nature. Also topical hemostasis products are most preferred in surgical procedures. Thus, increasing number of surgical procedures will favour the segmental growth.

While infusible hemostat segment to account for a significant market share of during the assessment period. As Infusible hemostats are among the most common and widely used hemostatic products for a number of bleeding management practices performed on patients suffering from blood clotting disorders such as hemophilia, Von Willebrand disease (vWD), and dysfibrinogenemia.

The Start-Up Ecosystem: How key Players are opening Frontiers for Future Growth?

Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. some of the startup companies operating in the hemostasis products market are AVS Electrotherm, Ortholink Marketing, Globalstar company, AGD Biomedicals, Sysmex.

  • Sysmex is a global market leader in haemostasis instrumentation. Sysmex has maintained a distribution agreement with Siemens a global leader in haemostasis reagents, forging a synergistic relationship that reinforces respective strengths in the hemostasis segment.

Competition Analysis

Key players in the global hemostasis products market are Medtronic, Johnson & Johnson, Baxter International, Pfizer, Becton, Dickinson, and Company (BD), B. Braun Melsungen AG, Tricol Biomedical, Hemostasis LLC, Teleflex Incorporated, CuraMedical BV, among various others

Recent updates from the industry are:

  • In July 2021- Baxter International Inc announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc. The transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio across the hospital, including in the operating room. PerClot has a global commercial presence with sales in more than 35 countries worldwide.
  • Hemostasis is committed to producing high quality medical devices that are safe and effective for their intended use. Hemostasis introduced. BoneSeal bone hemostat is a new generation, absorbable solution providing immediate and long-term hemostasis without immediately dissolving. BoneSeal hemostat works quickly and delivers better results for you and your patients.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.3% from 2022-2032

Market Value in 2022

US$ 1580 Million

Market Value in 2032

US$ 2638 Million

Base Year for Estimation

2021

Historical Data

2017-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Billion and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product
  • Application
  • End-use
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Greece
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Philippines
  • Australia
  • South Korea
  • New Zealand
  • GCC
  • South Africa
  • Argentina

Key Companies Profiled

  • Medtronic
  • Johnson & Johnson
  • Baxter International
  • Pfizer Inc.
  • Becton Dickinson and Company (BD)
  • B. Braun Melsungen AG
  • Tricol Biomedical
  • Hemostasis LL
  • Teleflex Incorporated
  • CuraMedical BV

Key Segments Covered in the Hemostasis Products Industry Analysis

Hemostasis Products Market by Product:

  • Topical Hemostasis Products
    • Gelatin
    • Polysaccharides
    • Oxidized Regenerated Cellulose
    • Collagen
  • Infusible Hemostasis Products
    • Platelet Concentrate from Donor Blood
    • Fresh Frozen Plasma (FFP)
    • Factor VIII
    • Prothrombin
  • Advanced Hemostasis Products
    • Flowable
    • Thrombin
    • Synthetic Sealants
    • Fibrin

Hemostasis Products Market by Application:

  • Hemostasis Products for Trauma
  • Hemostasis Products for Surgery
  • Hemostasis Products for Hemophilia
  • Hemostasis Products for Myocardial Infarction
  • Hemostasis Products for Others

Hemostasis Products Market by End Use:

  • Hemostasis Products in Hospitals
  • Hemostasis Products in Ambulatory Surgical Centers
  • Hemostasis Products in Others

Hemostasis Products Market by Region:

  • North America Hemostasis Products Market
  • Latin America Hemostasis Products Market
  • Europe Hemostasis Products Market
  • Asia Pacific Hemostasis Products Market
  • Middle East and Africa Hemostasis Products Market

Frequently Asked Questions

The global hemostasis products market is estimated at USD 1501 Billion in 2021.

The global hemostasis products market in 2022 is expected to secure US$ 1580 Million in 2022.

The global hemostasis products market is predicted to garner US$ 2638 Million by 2032.

From 2022-2032, sales of the hemostasis products market are expected to grow at a 5.3% CAGR

The U.S market is estimated to have a market share of 29.5% during the forecast period.

Based on products, topical hemostat segment is expected to dominate the market with a share of 68.5%.

An increase in the number of trauma and surgical procedures and the increasing prevalence of chronic blood disorders is expected to drive sales of hemostasis products.

Based on the application, the myocardial infraction segment accounts for share of 19.5% in the forecasting period.

Table of Content

1. Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. FMI Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Background and Foundation Data Points

    3.1. Need of the Hour for Industries

    3.2. Hemostasis Products – Strategic Priorities

    3.3. Life Cycle Stage

    3.4. Importance of Technology

    3.5. Use Cases of Hemostasis Products

    3.6. Forecast Factors: Relevance and Impact

    3.7. Investment Feasibility Matrix

    3.8. PESTLE Analysis

    3.9. Porter’s Five Forces Analysis

    3.10. Market Dynamics

        3.10.1. Drivers

        3.10.2. Restraints

        3.10.3. Opportunity Analysis

        3.10.4. Trend

4. Global Hemostasis Products Market Demand (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Value (US$ Mn) Analysis By Product, 2017-2021

    5.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2022-2032

        5.3.1. Topical

            5.3.1.1. Gelatin

            5.3.1.2. Polysaccharides

            5.3.1.3. Oxidized Regenerated Cellulose

            5.3.1.4. Collagen

        5.3.2. Infusible

            5.3.2.1. Platelet Concentrate from Donor Blood

            5.3.2.2. Fresh Frozen Plasma (FFP)

            5.3.2.3. Factor VIII

            5.3.2.4. Prothrombin

        5.3.3. Advanced

            5.3.3.1. Flowable

            5.3.3.2. Thrombin

            5.3.3.3. Synthetic Sealant

            5.3.3.4. Fibrin

    5.4. Market Attractiveness Analysis By Product

6. Global Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032, by Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By Application , 2017-2021

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        6.3.1. Trauma

        6.3.2. Surgery

        6.3.3. Hemophilia

        6.3.4. Myocardial Infarction

        6.3.5. Others

    6.4. Market Attractiveness Analysis By Application

7. Global Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032, by End Use

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Application , 2017-2021

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Others

    7.4. Market Attractiveness Analysis By End Use

8. Global Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032, by Region

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. Middle East and Africa (MEA)

    8.4. Market Attractiveness Analysis By Region

9. North America Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.3.1. By Country

            9.3.1.1. U.S.

            9.3.1.2. Canada

        9.3.2. By Product

        9.3.3. By Application

    9.4. Market Attractiveness Analysis

        9.4.1. By Country

        9.4.2. By Product

        9.4.3. By Application

10. Latin America Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        10.3.1. By Country

            10.3.1.1. Brazil

            10.3.1.2. Mexico

            10.3.1.3. Rest of Latin America

        10.3.2. By Product

        10.3.3. By Application

        10.3.4. By End Use

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Product

        10.4.3. By Application

        10.4.4. By End Use

11. Europe Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        11.3.1. By Country

            11.3.1.1. Germany

            11.3.1.2. France

            11.3.1.3. Italy

            11.3.1.4. Spain

            11.3.1.5. U.K

            11.3.1.6. Rest of Europe

        11.3.2. By Product

        11.3.3. By Application

        11.3.4. By End Use

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Product

        11.4.3. By Application

        11.4.4. By End Use

12. Asia Pacific Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        12.3.1. By Country

            12.3.1.1. China

            12.3.1.2. Japan

            12.3.1.3. South Korea

            12.3.1.4. Malaysia

            12.3.1.5. Singapore

            12.3.1.6. Australia

            12.3.1.7. New Zealand

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By End Use

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Product

        12.4.3. By Application

        12.4.4. By End Use

13. Middle East and Africa Hemostasis Products Market Analysis 2017-2021 and Forecast 2022-2032

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        13.3.1. By Country

            13.3.1.1. GCC Countries

            13.3.1.2. South Africa

            13.3.1.3. Israel

            13.3.1.4. Rest of Middle East and Africa (MEA)

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By End Use

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By Application

        13.4.4. By End Use

14. Market Structure Analysis

    14.1. Market Analysis by Tier of Companies

    14.2. Market Concentration

    14.3. Market Share Analysis of Top Players

    14.4. Market Presence Analysis

15. Competition Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Competition Deep Dive

    15.4. Medtronic

        15.4.1. Company Overview

        15.4.2. Product overview

        15.4.3. SWOT Analysis

        15.4.4. Key Developments

    15.5. Johnson & Johnson

        15.5.1. Company Overview

        15.5.2. Product overview

        15.5.3. SWOT Analysis

        15.5.4. Key Developments

    15.6. Baxter International

        15.6.1. Company Overview

        15.6.2. Product overview

        15.6.3. SWOT Analysis

        15.6.4. Key Developments

    15.7. Pfizer Inc.

        15.7.1. Company Overview

        15.7.2. Product overview

        15.7.3. SWOT Analysis

        15.7.4. Key Developments

    15.8. Becton Dickinson and Company (BD)

        15.8.1. Company Overview

        15.8.2. Product overview

        15.8.3. SWOT Analysis

        15.8.4. Key Developments

    15.9. B. Braun Melsungen AG

        15.9.1. Company Overview

        15.9.2. Product overview

        15.9.3. SWOT Analysis

        15.9.4. Key Developments

    15.10. Tricol Biomedical

        15.10.1. Company Overview

        15.10.2. Product overview

        15.10.3. SWOT Analysis

        15.10.4. Key Developments

    15.11. Hemostasis LL

        15.11.1. Company Overview

        15.11.2. Product overview

        15.11.3. SWOT Analysis

        15.11.4. Key Developments

    15.12. Teleflex Inc.

        15.12.1. Company Overview

        15.12.2. Product overview

        15.12.3. SWOT Analysis

        15.12.4. Key Developments

    15.13. CuraMedical BV

        15.13.1. Company Overview

        15.13.2. Product overview

        15.13.3. SWOT Analysis

        15.13.4. Key Developments

16. Assumptions And Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2017-2021

Table 2: Global Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2022-2032

Table 3: Global Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032

Table 4: Global Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2017-2021

Table 5: Global Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 6: Global Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 7: Global Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2017-2021

Table 8: Global Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 9: Global Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 10: Global Hemostasis Products Market Value (US$ Mn) Analysis, by Region, 2017-2021

Table 11: Global Hemostasis Products Market Value (US$ Mn) Analysis, by Region, 2022-2032

Table 12: Global Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Region, 2022-2032

Table 13: North America Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2017-2021

Table 14: North America Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 15: North America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 16: North America Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2017-2021

Table 17: North America Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2022-2032

Table 18: North America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032

Table 19: North America Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2017-2021

Table 20: North America Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 21: North America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 22: North America Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2017-2021

Table 23: North America Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 24: North America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 25: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2017-2021

Table 26: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 27: Latin America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 28: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2017-2021

Table 29: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2022-2032

Table 30: Latin America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032

Table 31: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2017-2021

Table 32: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 33: Latin America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 34: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2017-2021

Table 35: Latin America Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 36: Latin America Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 37: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2017-2021

Table 38: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 39: Europe Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 40: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2017-2021

Table 41: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2022-2032

Table 42: Europe Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032

Table 43: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2017-2021

Table 44: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 45: Europe Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 46: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2017-2021

Table 47: Europe Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 48: Europe Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 49: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2017-2021

Table 50: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 51: Asia Pacific Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 52: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2017-2021

Table 53: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2022-2032

Table 54: Asia Pacific Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032

Table 55: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2017-2021

Table 56: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 57: Asia Pacific Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 58: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2017-2021

Table 59: Asia Pacific Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 60: Asia Pacific Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 61: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2017-2021

Table 62: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 63: MEA Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 64: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2017-2021

Table 65: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by Product, 2022-2032

Table 66: MEA Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032

Table 67: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2017-2021

Table 68: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 69: MEA Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 70: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2017-2021

Table 71: MEA Hemostasis Products Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 72: MEA Hemostasis Products Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Hemostasis Products Market Value (US$ Mn) Historical Analysis, 2017-2021

Figure 2: Global Hemostasis Products Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 3: Global Hemostasis Products Market Value Y-o-Y Growth and Forecast, 2017-2032

Figure 4: Global Hemostasis Products Market Incremental $ Opportunity, 2022-2032

Figure 5: Global Hemostasis Products Market Share and BPS Analysis by Product, 2022 & 2032

Figure 6: Global Hemostasis Products Market Y-o-Y Growth Projections by Product, 2022-2032

Figure 7: Global Hemostasis Products Market Attractiveness Analysis by Product, 2022-2032

Figure 8: Global Hemostasis Products Market Share and BPS Analysis by Application, 2022 & 2032

Figure 9: Global Hemostasis Products Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 10: Global Hemostasis Products Market Attractiveness Analysis by Application, 2022-2032

Figure 11: Global Hemostasis Products Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 12: Global Hemostasis Products Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 13: Global Hemostasis Products Market Attractiveness Analysis by End Use, 2022-2032

Figure 14: Global Hemostasis Products Market Share and BPS Analysis by Region, 2022 & 2032

Figure 15: Global Hemostasis Products Market Y-o-Y Growth Projections by Region, 2022-2032

Figure 16: Global Hemostasis Products Market Attractiveness Analysis by Region, 2022-2032

Figure 17: North America Hemostasis Products Market Value (US$ Mn) Historical Analysis, 2017-2021

Figure 18: North America Hemostasis Products Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 19: North America Hemostasis Products Market Value Y-o-Y Growth and Forecast, 2032

Figure 20: North America Hemostasis Products Market Incremental $ Opportunity, 2022-2032

Figure 21: North America Hemostasis Products Market Share Analysis by Country, 2022 & 2032

Figure 22: North America Hemostasis Products Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 23: North America Hemostasis Products Market Attractiveness Analysis by Country, 2022-2032

Figure 24: North America Hemostasis Products Market Share and BPS Analysis by Product, 2022 & 2032

Figure 25: North America Hemostasis Products Market Y-o-Y Growth Projections by Product, 2022-2032

Figure 26: North America Hemostasis Products Market Attractiveness Analysis by Product, 2022-2032

Figure 27: North America Hemostasis Products Market Share and BPS Analysis by Application, 2022 & 2032

Figure 28: North America Hemostasis Products Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 29: North America Hemostasis Products Market Attractiveness Analysis by Application, 2022-2032

Figure 30: North America Hemostasis Products Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 31: North America Hemostasis Products Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 32: North America Hemostasis Products Market Attractiveness Analysis by End Use, 2022-2032

Figure 33: Latin America Hemostasis Products Market Value (US$ Mn) Historical Analysis, 2017-2021

Figure 34: Latin America Hemostasis Products Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 35: Latin America Hemostasis Products Market Value Y-o-Y Growth and Forecast, 2017-2032

Figure 36: Latin America Hemostasis Products Market Incremental $ Opportunity, 2022-2032

Figure 37: Latin America Hemostasis Products Market Share Analysis by Country, 2022 & 2032

Figure 38: Latin America Hemostasis Products Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 39: Latin America Hemostasis Products Market Attractiveness Analysis by Country, 2022-2032

Figure 40: Latin America Hemostasis Products Market Share and BPS Analysis by Product, 2022 & 2032

Figure 41: Latin America Hemostasis Products Market Y-o-Y Growth Projections by Product, 2022-2032

Figure 42: Latin America Hemostasis Products Market Attractiveness Analysis by Product, 2022-2032

Figure 43: Latin America Hemostasis Products Market Share and BPS Analysis by Application, 2022 & 2032

Figure 44: Latin America Hemostasis Products Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 45: Latin America Hemostasis Products Market Attractiveness Analysis by Application, 2022-2032

Figure 46: Latin America Hemostasis Products Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 47: Latin America Hemostasis Products Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 48: Latin America Hemostasis Products Market Attractiveness Analysis by End Use, 2022-2032

Figure 49: Europe Hemostasis Products Market Value (US$ Mn) Historical Analysis, 2017-2021

Figure 50: Europe Hemostasis Products Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 51: Europe Hemostasis Products Market Value Y-o-Y Growth and Forecast, 2017-2032

Figure 52: Europe Hemostasis Products Market Incremental $ Opportunity, 2022-2032

Figure 53: Europe Hemostasis Products Market Share Analysis by Country, 2022 & 2032

Figure 54: Europe Hemostasis Products Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 55: Europe Hemostasis Products Market Attractiveness Analysis by Country, 2022-2032

Figure 56: Europe Hemostasis Products Market Share and BPS Analysis by Product, 2022 & 2032

Figure 57: Europe Hemostasis Products Market Y-o-Y Growth Projections by Product, 2022-2032

Figure 58: Europe Hemostasis Products Market Attractiveness Analysis by Product, 2022-2032

Figure 59: Europe Hemostasis Products Market Share and BPS Analysis by Application, 2022 & 2032

Figure 60: Europe Hemostasis Products Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 61: Europe Hemostasis Products Market Attractiveness Analysis by Application, 2022-2032

Figure 62: Europe Hemostasis Products Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 63: Europe Hemostasis Products Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 64: Europe Hemostasis Products Market Attractiveness Analysis by End Use, 2022-2032

Figure 65: Asia Pacific Hemostasis Products Market Value (US$ Mn) Historical Analysis, 2017-2021

Figure 66: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 67: Asia Pacific Hemostasis Products Market Value Y-o-Y Growth and Forecast, 2017-2032

Figure 68: Asia Pacific Hemostasis Products Market Incremental $ Opportunity, 2022-2032

Figure 69: Asia Pacific Hemostasis Products Market Share Analysis by Country, 2022 & 2032

Figure 70: Asia Pacific Hemostasis Products Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 71: Asia Pacific Hemostasis Products Market Attractiveness Analysis by Country, 2022-2032

Figure 72: Asia Pacific Hemostasis Products Market Share and BPS Analysis by Product, 2022 & 2032

Figure 73: Asia Pacific Hemostasis Products Market Y-o-Y Growth Projections by Product, 2022-2032

Figure 74: Asia Pacific Hemostasis Products Market Attractiveness Analysis by Product, 2022-2032

Figure 75: Asia Pacific Hemostasis Products Market Share and BPS Analysis by Application, 2022 & 2032

Figure 76: Asia Pacific Hemostasis Products Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 77: Asia Pacific Hemostasis Products Market Attractiveness Analysis by Application, 2022-2032

Figure 78: Asia Pacific Hemostasis Products Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 79: Asia Pacific Hemostasis Products Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 80: Asia Pacific Hemostasis Products Market Attractiveness Analysis by End Use, 2022-2032

Figure 81: MEA Hemostasis Products Market Value (US$ Mn) Historical Analysis, 2017-2021

Figure 82: MEA Hemostasis Products Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 83: MEA Hemostasis Products Market Value Y-o-Y Growth and Forecast, 2017-2032

Figure 84: MEA Hemostasis Products Market Incremental $ Opportunity, 2022-2032

Figure 85: MEA Hemostasis Products Market Share Analysis by Country, 2022 & 2032

Figure 86: MEA Hemostasis Products Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 87: MEA Hemostasis Products Market Attractiveness Analysis by Country, 2022-2032

Figure 88: MEA Hemostasis Products Market Share and BPS Analysis by Product, 2022 & 2032

Figure 89: MEA Hemostasis Products Market Y-o-Y Growth Projections by Product, 2022-2032

Figure 90: MEA Hemostasis Products Market Attractiveness Analysis by Product, 2022-2032

Figure 91: MEA Hemostasis Products Market Share and BPS Analysis by Application, 2022 & 2032

Figure 92: MEA Hemostasis Products Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 93: MEA Hemostasis Products Market Attractiveness Analysis by Application, 2022-2032

Figure 94: MEA Hemostasis Products Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 95: MEA Hemostasis Products Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 96: MEA Hemostasis Products Market Attractiveness Analysis by End Use, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Hemostatic Gels Market

Published : June 2022

Testing Equipment

Hemostasis Analyzers Market

Published : February 2019

Healthcare

Hemostasis Testing Systems Market

Published : March 2016

Healthcare

Hemostats For Wound Closure Market

Published : March 2022

Google translate

Hemostasis Products Market